ReiThera Srl
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of GRAd-COV2 for the Prevention of COVID-19 in Adults (NCT04791423) | ReiThera Srl | 2021-03-15 |
| Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine (NCT04528641) | ReiThera Srl | 2020-08-10 |
| RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections. (NCT01805921) | ReiThera Srl | 2013-05-01 |
| Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients (NCT01701336) | ReiThera Srl | 2012-03-01 |
| Study of a New MVA Vaccine for Hepatitis C Virus (NCT01296451) | ReiThera Srl | 2010-12-01 |
| Study of a Novel Therapeutic Vaccine for Hepatitis C Virus (NCT01094873) | ReiThera Srl | 2009-11-01 |
| A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV) (NCT01070407) | ReiThera Srl | 2007-07-01 |
Track ReiThera Srl automatically
Every clearance here is in the API, with alerts when new ones post.